Full Episode: Innovating Tomorrow’s Medicine ft. Rick Fultz, CEO of Acurion, Inc. whose mission is to bring the power of precision medicine to more cancer patients, faster.In this exclusive preview, Rick shares a glimpse into how Acurion is transforming the field of precision oncology using next-generation science and strategic biotech leadership.➡️ Full episode launches on 30 October 🔔 Subscribe and hit the bell so you don’t miss it!🎙️ About the Show:Innovating Tomorrow’s Medicine features bold

Treponema pallidum, the causative agent of syphilis, has been around for what seems like forever, causing major outbreaks throughout the millennia and continuing to spread at high rates, globally, into today. When it comes to diagnostic testing, some tests like RPR and VDRL have stood the test of time, having been implemented in the late 1930s and 1940s, and are now used in combination with contemporary methods like EIAs and chemiluminescent assays as the reference standard method to diagnosis

In today’s Pharmaceutical Executive Daily, we cover Eli Lilly’s partnership with NVIDIA to develop an AI supercomputer for drug discovery, a surge in biotech funding rounds and public offerings, and the FDA approval of Merck’s Winrevair for pulmonary arterial hypertension.

In this podcast episode, Jokūbas Leikauskas, Editor, BioInsights, speaks to Trevor Hallam, who served as Chief Scientific Officer of Sail Biomedicines until July 2025. The interview, recorded in June 2025, explores advances in RNA therapeutics, particularly circular RNA (circRNA or eRNA) technologies, and how they may help overcome current limitations in delivery, durability, and specificity for applications such as CAR-T cell therapies and autoimmune disease treatment.

Sit down with Kate Shaw, Founder and CEO of Innovative Trials, to explore how humanized, bespoke approaches are reshaping patient recruitment and retention in clinical research. Kate breaks down the difference between one-to-one, in-country support and automated recruitment systems, showing how local expertise and cultural understanding can dramatically improve trial outcomes. You’ll also hear how the Patient Support Center and dedicated patient navigators guide participants step by step, ens...

Darshan Kulkarni highlights that to stay compliant with the FDA, companies don’t need an exhaustive set of SOPs—just the essential ones. Inspectors primarily focus on SOPs covering informed consent, adverse event reporting, drug/device accountability, source documentation, PI oversight, protocol deviations, and record retention. He emphasizes keeping SOPs concise, practical, and enforceable, training staff consistently, and expanding them only as operational needs grow. Support the show

In this Best Practices in Keratoconus Management podcast episode, Brandon D. Ayres, MD, welcomes Tomas Navratil, PhD, to examine the crucial role of oxygen in corneal crosslinking. Dr. Navratil explains the underlying science of oxygen’s involvement in the crosslinking reaction and how varying oxygen levels can affect treatment efficacy. The discussion highlights emerging strategies and new technologies that aim to optimize oxygen delivery and enhance outcomes for patients with keratoconus.

“The key word is curiosity. That curiosity helps you to question and improve not only yourself, but also your processes, your systems, and how you interact with different stakeholders.”Jeroen Janssens, External Manufacturing Technical Operations Lead at MSD, provides insights through a technical lens on how one of the world’s largest pharmaceutical companies approaches biologics manufacturing partnerships. With over 15 years of experience spanning validation engineering to director-level leadership,

In this special Oxygen Advantage® conversation, Patrick McKeown speaks with Rostislav Václavek, Master Instructor for Oxygen Advantage® and Buteyko Clinic International®, and the breathing coach of UFC fighter Jiří Procházka.Together, they explore the science and practice of breath training — from recovery and focus to repeated sprint ability and endurance under fatigue.Rostislav shares insights from his three-year collaboration with Jiří, explaining how breath-hold sprints, nasal breathing, and

Dr. Don and Professor Ben talk about the risks from drinking a 24 hour old Pumpkin Spice Latte. Dr. Don - risky ☣️ Professor Ben - not risky 👍🏼 Home – KonMari | The Official Website of Marie Kondo Pumpkin Spice Latte: Starbucks Coffee Company Significance of Bacterial Spores in Milk - ScienceDirect Short communication: Bacterial ecology of high-temperature, short-time pasteurized milk processed in the United States - ScienceDirect

AABP executive Director Dr. Fred Gingrich reviews a paper published in The Bovine Practitioner with two of the authors. Joining today are Dr. Greg Habing, professor in the Department of Preventive Medicine at The Ohio State University College of Veterinary Medicine, and Dr. Emily Nogay, clinical assistant professor at The Ohio State University Large Animal Ambulatory Services. Salmonella Dublin is a host-adapted and zoonotic pathogen affecting many dairy farms. It can be associat...

👉 Para receber diretamente os áudios no seu celular, entre para o grupo: 🔗 https://site.vedanta.com.br/lead/cast-jz Saiba mais sobre esse conhecimento em: https://www.instagram.com/vedanta.soma

In this classic episode of Weirdhouse Cinema, Rob and Joe kick off the Halloween season with the notorious low-budget 1981 Italian slasher film “Absurd,” directed by Joe D’Amato and starring George Eastman. (originally published 9/27/2024)See omnystudio.com/listener for privacy information.

On October 30, 2025, at 9:00 a.m. PT/12:00 p.m. ET, the Salk Institute holds a special live, video edition of our Beyond Lab Walls podcast as we explore why science can't wait. Salk's Vice President of Advancement Michelle Chamberlain will host an in-depth conversation with Chief Science Officer Jan Karlseder and Chief Financial Officer Marie Carter-Dubois about the urgent importance of foundational research—and how it depends on the vital partnership between federal funding and private

Evolution of Bioenergetics – with a Focus on ProkaryotesHadean Eon (4.6–4 billion years ago): Chemical evolution → Prerequisite for complex biomoleculesArchaean Eon (from approx. 4 billion years ago): Biological evolution: Emergence of the first prokaryotes and energy production13 Stages of Bioenergetic EvolutionStage 0: Initial conditionsStage 1: GlycolysisStage 2: Binding of H⁺ to organic moleculesStage 3: Proton pumpStage 4: Electron transport chain developsProkaryotes as “inventors”Geology and

This episode provides excerpts detailing the spiritual journey of retired U.S. Navy SEAL Chadd Wright, focusing on his supposed demonic encounter during a deployment in Germany, which led to his conversion from atheism to fervent Christianity. The episode explains Wright's background, including his rigorous SEAL training and subsequent military career with Team 8, contextualizing the supernatural experience against his hardened, secular worldview. The source chronicles the unsettling events leading

Jonny Miller is the creator of Nervous System Mastery, a transformative training program that teaches thousands of people how to regulate stress, unlock emotional resilience, and reconnect with their bodies. He’s also the host of The Inner Frontier podcast and a TEDx speaker whose work bridges neuroscience, trauma, and the physiology of calm.Emotions aren’t what you think they are — they don’t live in your “mind,” but in the dynamic language of your body. Jonny’s journey from burnout and grief to

Наука — это про смелость мыслить шире и отправиться туда, где до тебя никого не было 🛤️Этим выпуском мы, Маша Романенко и Аня Валина, открываем серию историй о великих исследовательницах прошлого. Сегодня мы говорим о первой русской женщине, получившей степень доктора медицинских наук, — о Надежде Прокофьевне Сусловой 💉🩺 • Как ей удалось поступить в университет, когда в приёмной комиссии говорили "женщинам нельзя"? • Как она смогла преодолеть скепсис коллег, ограничения эпохи и не потерять веру

CEO Jason Cole walks us through this unique science, which is based on work that co-founder Diane Mathis and colleagues published in Cell in 2022. The T1D program is scheduled to be in the clinic by late 2026.

Think about the thing you’ve practiced more than anything else in the world. Maybe it’s painting. Or writing. Or playing baseball. Now, imagine you wake up one day, and you just can’t do it. You’re not sick. You’re not injured. But suddenly, that one thing is impossible. (Originally published in 2024) Guests: Rick Ankiel, former Major League Baseball star; Sally Akehurst, sports psychologist and a dean at University of Roehampton, London; Steven Frucht, neurologist at NYU Langone For show